5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.14%
Negative revenue growth while UPM.HE stands at 5.83%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-11.95%
Negative gross profit growth while UPM.HE is at 25.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
-4.15%
Negative EBIT growth while UPM.HE is at 85.53%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.15%
Negative operating income growth while UPM.HE is at 85.53%. Joel Greenblatt would press for urgent turnaround measures.
-2.59%
Negative net income growth while UPM.HE stands at 104.18%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.35%
Negative EPS growth while UPM.HE is at 104.44%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.35%
Negative diluted EPS growth while UPM.HE is at 104.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.70%
Share change of 0.70% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.84%
Diluted share change of 1.84% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-55.90%
Negative OCF growth while UPM.HE is at 3.25%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-66.85%
Negative FCF growth while UPM.HE is at 52.94%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-29.30%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
22.74%
5Y revenue/share CAGR above 1.5x UPM.HE's 3.23%. David Dodd would look for consistent product or market expansions fueling outperformance.
9.81%
Positive 3Y CAGR while UPM.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
177.06%
10Y OCF/share CAGR above 1.5x UPM.HE's 9.96%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-7.70%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
10.84%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
302.27%
Net income/share CAGR at 50-75% of UPM.HE's 541.22%. Martin Whitman might question if the firm’s product or cost base lags behind.
344.99%
5Y net income/share CAGR above 1.5x UPM.HE's 82.15%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
39.06%
3Y net income/share CAGR 75-90% of UPM.HE's 49.69%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
50.41%
10Y equity/share CAGR 1.25-1.5x UPM.HE's 38.68%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
71.58%
5Y equity/share CAGR above 1.5x UPM.HE's 29.37%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
30.65%
3Y equity/share CAGR above 1.5x UPM.HE's 10.84%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.69%
Firm’s AR is declining while UPM.HE shows 1.42%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.61%
Inventory shrinking or stable vs. UPM.HE's 9.18%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.38%
Asset growth at 50-75% of UPM.HE's 5.92%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.29%
50-75% of UPM.HE's 8.41%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-0.20%
We’re deleveraging while UPM.HE stands at 0.23%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.59%
SG&A growth of 3.59% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.